600530.SH
ST交昂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 3.61
−2.43%Jul 31, 2026, 12:43 UTC
Jiaoda Angli received a Penalty Notice from the Shanghai Regulatory Bureau for false statements in its 2023 accounting correction announcement and 2024 annual report, facing a 4 million yuan fine and a risk warning on its stock, with executives Ji Lin, Ji Min, and Cao Yi each facing fines of 2 million, 1 million, and 1 million yuan respectively.